Jakob P. Schneider - Concepedia

Concepedia

Author

Jakob P. Schneider

Cleveland Clinic

Also Known As

J P Schneider, Jakob P Schneider, Jakob P. Schneider, Jakob Schneider

24

Publications

1.7K

Citations

14

H-Index

41

Concepts

All Affiliations

Cleveland Clinic Cleveland Foundation

JP

About

Jakob P. Schneider is an author at Cleveland Clinic specializing in medicine, cardiovascular disease, and percutaneous coronary intervention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	726
2	Public Health	2	2	166
3	Biomedical Engineering	2	2	109
4	Engineering	1	1	18
5	Cardiothoracic Surgery	1	1	34

Jakob P. Schneider

×

14

Publications

1.7K

Citations

14

H-Index

	Year	Citations
Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features Sorin J. Brener, Bruce W. Lytle, Ivan P. Casserly, Circulation	2004	267
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention Derek P. Chew, Deepak L. Bhatt, Mark Robbins, Circulation	2001	260
Death Following Creatine Kinase-MB Elevation After Coronary Intervention Stephen G. Ellis, Derek P. Chew, Albert W. Chan, Circulation	2002	209
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions Albert W. Chan, Deepak L. Bhatt, Derek P. Chew, Circulation	2003	205
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality Sorin J. Brener, Bruce W. Lytle, Jakob P. Schneider, Journal of the American College of Cardiology Transplantation SurgeryUrologySurgical PathologyCk-mb ElevationThree-year Mortality	2002	179
Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein Derek P. Chew, Deepak L. Bhatt, Mark Robbins, The American Journal of Cardiology InflammationPercutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicine	2001	135
Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention Stephen G. Ellis, Patrick L. Whitlow, Russell Raymond, The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseLong-term SurvivalSurgeryValvular Heart Disease	2002	132
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade Fernando Cura, Samir Kapadia, Philippe L. L’Allier, The American Journal of Cardiology ThrombosisPercutaneous Coronary InterventionFemoral Closure DevicesCardiovascular DiseaseBlood Platelet	2000	91
Percutaneous Transluminal Coronary Angioplasty: Jakob P. Schneider, A Grüntzig Pathology - Research and Practice Percutaneous Coronary InterventionCardiovascular DiseaseVascular SurgerySurgeryMedicine	1985	84
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting Stephen G. Ellis, A. Michael Lincoff, Patrick L. Whitlow, The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseMedicineCardiovascular PharmacologyCoronary Revascularization	2002	35

Page 1